These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6773281)

  • 21. Chromosome aberrations in X-irradiated and caffeine treated L5178Y-S cells during mitotic delay.
    Bocian E; Lerczak K; Rosiek O; Ziemba-Zółtowska B
    Bull Acad Pol Sci Biol; 1980; 28(1-2):125-32. PubMed ID: 7272824
    [No Abstract]   [Full Text] [Related]  

  • 22. Allosensitization protects against lethal challenge with a syngeneic mouse lymphoma.
    Bear RH; Roholt OA; Pressman D
    Transplant Proc; 1980 Mar; 12(1):150-1. PubMed ID: 7368286
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternate hypothesis for the bimodal size distribution of mutant colonies of L5178Y mouse lymphoma cells.
    Mitchell AD
    Environ Mol Mutagen; 1997; 29(4):431-3. PubMed ID: 9212795
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation and thermal characteristics of mouse lymphoma cells and their radiation-sensitive mutant.
    Baba Y; Yasunaga T; Uozumi H; Takahashi M; Sawada S
    Radiat Med; 1988; 6(5):232-9. PubMed ID: 3231725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some problems in using density gradient centrifugation for synchronization of L5178Y-S cells.
    Cymerman U; Beer JZ
    Neoplasma; 1980; 27(4):429-36. PubMed ID: 7453858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced pinosome formation in a cell-fusion-impaired mutant of mouse lymphocytic cell line L5178Y.
    Pauw PG; Biagi KG; Stadler JK
    J Cell Physiol; 1986 Feb; 126(2):243-8. PubMed ID: 3944207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
    Fallarino F; Uyttenhove C; Boon T; Gajewski TF
    J Immunol; 1996 Feb; 156(3):1095-100. PubMed ID: 8557984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
    Townsend SE; Su FW; Atherton JM; Allison JP
    Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
    Chow DA
    J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TK locus mutation assay: comparison of L5178Y and TK6 cell lines].
    Shuai PQ; Zhang LS; Wang YJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):650-3. PubMed ID: 15460410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
    Romani L; Fioretti MC; Bonmassar E
    Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression.
    Zhang ZY; Chow DA
    J Immunol; 1997 Jul; 159(1):344-50. PubMed ID: 9200472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity.
    Grohmann U; Belladonna ML; Allegrucci M; Silla S; Schiaffella E; Fioretti MC; Puccetti P
    Viral Immunol; 1994; 7(4):155-67. PubMed ID: 7576030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of horse and fetal calf serum on the expression of tumor-associated antigen and tumorigenicity of L5178Y leukemia/lymphoma cells.
    Rabinovsky ED; Yang TJ
    Leuk Res; 1986; 10(11):1331-40. PubMed ID: 3796035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The induction of mutants in L5178Y mouse lymphoma cells by 4-chloromethylbiphenyl.
    Arlett CF; Muriel WJ; Cole J; Lowe J
    Mutat Res; 1982; 100(1-4):253-6. PubMed ID: 7057756
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity.
    Gordon LB; Nolan SC; Cserr HF; Knopf PM; Harling-Berg CJ
    J Immunol; 1997 Sep; 159(5):2399-408. PubMed ID: 9278331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultraviolet wavelength regions implicated in toxic and mutagenic effects on broad spectrum radiation from fluorescent lamps on L5178Y mouse lymphoma cells.
    Jacobson E; Krell K
    Mutat Res; 1979 Oct; 62(3):533-8. PubMed ID: 514297
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA repair in a UV-sensitive mutant of a mouse cell line.
    Sato K; Setlow RB
    Mutat Res; 1981 Dec; 84(2):443-55. PubMed ID: 7335106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.